Alector (ALEC) Stock: Buy, Sell, or Hold?
ALEC - Alector, Inc. Common Stock
$2.14
0.00 (0.00%)
β²
5d:
-14.74%
30d:
-0.47%
90d:
+36.31%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When ALEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: ALEC is down 14.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: ALEC is down 14.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALEC is currently trading at $2.14, which is considered fair relative to its 30-day fair value range of $1.84 to $2.47.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $2.00, while resistance sits at $2.76.
Market Sentiment: ALEC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.10 (+44.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $2.00, while resistance sits at $2.76.
Market Sentiment: ALEC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.10 (+44.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.84 -
$2.47
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.9% below Wall St target ($3.10)
- WARNING: Composite score 38/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.84 -
$2.47
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.00
Resistance Level
$2.76
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.87
Wall Street Target
$3.10
(+44.9%)
Revenue Growth (YoY)
-57.8%
Earnings Growth (YoY)
-86.3%
Share & Embed Analysis
Last updated: September 12, 2026 5:44 AM ET
Data refreshes hourly during market hours. Next update: 6:44 AM
Data refreshes hourly during market hours. Next update: 6:44 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Grace Wong-Sarad
SELL
1820 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 47 HOLD |